nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2A6—Fluorouracil—urinary bladder cancer	0.167	0.301	CbGbCtD
Chlorzoxazone—CYP3A4—Thiotepa—urinary bladder cancer	0.103	0.185	CbGbCtD
Chlorzoxazone—CYP2E1—Etoposide—urinary bladder cancer	0.0921	0.166	CbGbCtD
Chlorzoxazone—CYP1A2—Fluorouracil—urinary bladder cancer	0.0638	0.115	CbGbCtD
Chlorzoxazone—CYP1A2—Etoposide—urinary bladder cancer	0.0533	0.0958	CbGbCtD
Chlorzoxazone—CYP2D6—Doxorubicin—urinary bladder cancer	0.0299	0.0538	CbGbCtD
Chlorzoxazone—CYP3A4—Etoposide—urinary bladder cancer	0.0279	0.0502	CbGbCtD
Chlorzoxazone—CYP3A4—Doxorubicin—urinary bladder cancer	0.019	0.0342	CbGbCtD
Chlorzoxazone—CYP1A2—urine—urinary bladder cancer	0.0105	0.0869	CbGeAlD
Chlorzoxazone—CYP2E1—urine—urinary bladder cancer	0.00941	0.0782	CbGeAlD
Chlorzoxazone—KCNMA1—prostate gland—urinary bladder cancer	0.00855	0.0711	CbGeAlD
Chlorzoxazone—CYP3A4—urine—urinary bladder cancer	0.00757	0.0629	CbGeAlD
Chlorzoxazone—CYP2D6—urine—urinary bladder cancer	0.00745	0.0619	CbGeAlD
Chlorzoxazone—CYP2A6—prostate gland—urinary bladder cancer	0.00715	0.0594	CbGeAlD
Chlorzoxazone—KCNMA1—epithelium—urinary bladder cancer	0.00629	0.0522	CbGeAlD
Chlorzoxazone—KCNMA1—smooth muscle tissue—urinary bladder cancer	0.00606	0.0503	CbGeAlD
Chlorzoxazone—CYP2A6—seminal vesicle—urinary bladder cancer	0.00604	0.0502	CbGeAlD
Chlorzoxazone—KCNMA1—renal system—urinary bladder cancer	0.00583	0.0485	CbGeAlD
Chlorzoxazone—KCNMA1—female reproductive system—urinary bladder cancer	0.00467	0.0388	CbGeAlD
Chlorzoxazone—CYP2A6—vagina—urinary bladder cancer	0.00353	0.0293	CbGeAlD
Chlorzoxazone—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.00352	0.0353	CcSEcCtD
Chlorzoxazone—Malaise—Valrubicin—urinary bladder cancer	0.00342	0.0343	CcSEcCtD
Chlorzoxazone—CYP2E1—prostate gland—urinary bladder cancer	0.00338	0.0281	CbGeAlD
Chlorzoxazone—Drowsiness—Mitomycin—urinary bladder cancer	0.00335	0.0336	CcSEcCtD
Chlorzoxazone—Discomfort—Valrubicin—urinary bladder cancer	0.00319	0.032	CcSEcCtD
Chlorzoxazone—Petechiae—Gemcitabine—urinary bladder cancer	0.00308	0.0308	CcSEcCtD
Chlorzoxazone—CYP2E1—seminal vesicle—urinary bladder cancer	0.00286	0.0237	CbGeAlD
Chlorzoxazone—KCNMA1—lymph node—urinary bladder cancer	0.00273	0.0227	CbGeAlD
Chlorzoxazone—CYP1A1—epithelium—urinary bladder cancer	0.00272	0.0226	CbGeAlD
Chlorzoxazone—CYP1A2—renal system—urinary bladder cancer	0.00256	0.0213	CbGeAlD
Chlorzoxazone—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00255	0.0256	CcSEcCtD
Chlorzoxazone—CYP1A1—renal system—urinary bladder cancer	0.00252	0.021	CbGeAlD
Chlorzoxazone—CYP1A1—urethra—urinary bladder cancer	0.00248	0.0206	CbGeAlD
Chlorzoxazone—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.00243	0.0243	CcSEcCtD
Chlorzoxazone—Malaise—Mitomycin—urinary bladder cancer	0.00236	0.0236	CcSEcCtD
Chlorzoxazone—CYP2E1—renal system—urinary bladder cancer	0.0023	0.0191	CbGeAlD
Chlorzoxazone—CYP2E1—urethra—urinary bladder cancer	0.00226	0.0188	CbGeAlD
Chlorzoxazone—Discomfort—Mitomycin—urinary bladder cancer	0.0022	0.0221	CcSEcCtD
Chlorzoxazone—Dizziness—Valrubicin—urinary bladder cancer	0.00205	0.0205	CcSEcCtD
Chlorzoxazone—CYP1A1—female reproductive system—urinary bladder cancer	0.00202	0.0168	CbGeAlD
Chlorzoxazone—Rash—Valrubicin—urinary bladder cancer	0.00195	0.0196	CcSEcCtD
Chlorzoxazone—Dermatitis—Valrubicin—urinary bladder cancer	0.00195	0.0196	CcSEcCtD
Chlorzoxazone—Somnolence—Mitomycin—urinary bladder cancer	0.0019	0.019	CcSEcCtD
Chlorzoxazone—CYP3A4—renal system—urinary bladder cancer	0.00185	0.0154	CbGeAlD
Chlorzoxazone—CYP2E1—female reproductive system—urinary bladder cancer	0.00184	0.0153	CbGeAlD
Chlorzoxazone—CYP1A1—vagina—urinary bladder cancer	0.00183	0.0152	CbGeAlD
Chlorzoxazone—CYP2D6—renal system—urinary bladder cancer	0.00182	0.0151	CbGeAlD
Chlorzoxazone—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00181	0.0181	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00176	0.0176	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.00171	0.0172	CcSEcCtD
Chlorzoxazone—Petechiae—Methotrexate—urinary bladder cancer	0.00157	0.0158	CcSEcCtD
Chlorzoxazone—CYP3A4—female reproductive system—urinary bladder cancer	0.00148	0.0123	CbGeAlD
Chlorzoxazone—Petechiae—Epirubicin—urinary bladder cancer	0.00147	0.0148	CcSEcCtD
Chlorzoxazone—CYP2D6—female reproductive system—urinary bladder cancer	0.00146	0.0121	CbGeAlD
Chlorzoxazone—Dizziness—Mitomycin—urinary bladder cancer	0.00141	0.0141	CcSEcCtD
Chlorzoxazone—Petechiae—Doxorubicin—urinary bladder cancer	0.00136	0.0137	CcSEcCtD
Chlorzoxazone—Rash—Mitomycin—urinary bladder cancer	0.00135	0.0135	CcSEcCtD
Chlorzoxazone—Dermatitis—Mitomycin—urinary bladder cancer	0.00134	0.0135	CcSEcCtD
Chlorzoxazone—CYP1A1—lymph node—urinary bladder cancer	0.00118	0.00983	CbGeAlD
Chlorzoxazone—Ecchymosis—Methotrexate—urinary bladder cancer	0.00117	0.0117	CcSEcCtD
Chlorzoxazone—Ecchymosis—Epirubicin—urinary bladder cancer	0.0011	0.011	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00103	0.0103	CcSEcCtD
Chlorzoxazone—Ecchymosis—Doxorubicin—urinary bladder cancer	0.00101	0.0102	CcSEcCtD
Chlorzoxazone—Malaise—Gemcitabine—urinary bladder cancer	0.000998	0.01	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000957	0.00959	CcSEcCtD
Chlorzoxazone—Somnolence—Thiotepa—urinary bladder cancer	0.000954	0.00957	CcSEcCtD
Chlorzoxazone—Dyspepsia—Thiotepa—urinary bladder cancer	0.000945	0.00947	CcSEcCtD
Chlorzoxazone—Discomfort—Gemcitabine—urinary bladder cancer	0.000931	0.00933	CcSEcCtD
Chlorzoxazone—Malaise—Cisplatin—urinary bladder cancer	0.00093	0.00932	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000927	0.00929	CcSEcCtD
Chlorzoxazone—Discomfort—Fluorouracil—urinary bladder cancer	0.000915	0.00917	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000903	0.00905	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000888	0.0089	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000885	0.00887	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.000879	0.00882	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000877	0.00879	CcSEcCtD
Chlorzoxazone—Discomfort—Cisplatin—urinary bladder cancer	0.000868	0.0087	CcSEcCtD
Chlorzoxazone—Malaise—Etoposide—urinary bladder cancer	0.000852	0.00854	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000842	0.00844	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.000814	0.00816	CcSEcCtD
Chlorzoxazone—Somnolence—Gemcitabine—urinary bladder cancer	0.000803	0.00805	CcSEcCtD
Chlorzoxazone—Discomfort—Etoposide—urinary bladder cancer	0.000795	0.00797	CcSEcCtD
Chlorzoxazone—Somnolence—Fluorouracil—urinary bladder cancer	0.000789	0.00791	CcSEcCtD
Chlorzoxazone—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000782	0.00783	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00078	0.00782	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000771	0.00773	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000767	0.00768	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000744	0.00746	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000732	0.00733	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000727	0.00728	CcSEcCtD
Chlorzoxazone—Drowsiness—Methotrexate—urinary bladder cancer	0.000724	0.00726	CcSEcCtD
Chlorzoxazone—Dizziness—Thiotepa—urinary bladder cancer	0.00071	0.00712	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000694	0.00695	CcSEcCtD
Chlorzoxazone—Somnolence—Etoposide—urinary bladder cancer	0.000686	0.00687	CcSEcCtD
Chlorzoxazone—Drowsiness—Epirubicin—urinary bladder cancer	0.000678	0.00679	CcSEcCtD
Chlorzoxazone—Rash—Thiotepa—urinary bladder cancer	0.000677	0.00678	CcSEcCtD
Chlorzoxazone—Dermatitis—Thiotepa—urinary bladder cancer	0.000676	0.00678	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000666	0.00667	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000635	0.00637	CcSEcCtD
Chlorzoxazone—Drowsiness—Doxorubicin—urinary bladder cancer	0.000627	0.00629	CcSEcCtD
Chlorzoxazone—Dizziness—Fluorouracil—urinary bladder cancer	0.000587	0.00589	CcSEcCtD
Chlorzoxazone—Rash—Gemcitabine—urinary bladder cancer	0.000569	0.00571	CcSEcCtD
Chlorzoxazone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000569	0.0057	CcSEcCtD
Chlorzoxazone—Rash—Fluorouracil—urinary bladder cancer	0.00056	0.00561	CcSEcCtD
Chlorzoxazone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000559	0.00561	CcSEcCtD
Chlorzoxazone—Rash—Cisplatin—urinary bladder cancer	0.000531	0.00532	CcSEcCtD
Chlorzoxazone—Dermatitis—Cisplatin—urinary bladder cancer	0.00053	0.00532	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000525	0.00526	CcSEcCtD
Chlorzoxazone—Malaise—Methotrexate—urinary bladder cancer	0.00051	0.00512	CcSEcCtD
Chlorzoxazone—Dizziness—Etoposide—urinary bladder cancer	0.00051	0.00511	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000491	0.00493	CcSEcCtD
Chlorzoxazone—Rash—Etoposide—urinary bladder cancer	0.000486	0.00487	CcSEcCtD
Chlorzoxazone—Dermatitis—Etoposide—urinary bladder cancer	0.000486	0.00487	CcSEcCtD
Chlorzoxazone—Malaise—Epirubicin—urinary bladder cancer	0.000478	0.00479	CcSEcCtD
Chlorzoxazone—Discomfort—Methotrexate—urinary bladder cancer	0.000476	0.00477	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000462	0.00463	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000455	0.00456	CcSEcCtD
Chlorzoxazone—Discomfort—Epirubicin—urinary bladder cancer	0.000445	0.00447	CcSEcCtD
Chlorzoxazone—Malaise—Doxorubicin—urinary bladder cancer	0.000442	0.00443	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000432	0.00433	CcSEcCtD
Chlorzoxazone—Discomfort—Doxorubicin—urinary bladder cancer	0.000412	0.00413	CcSEcCtD
Chlorzoxazone—Somnolence—Methotrexate—urinary bladder cancer	0.000411	0.00412	CcSEcCtD
Chlorzoxazone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000407	0.00408	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.0004	0.00401	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000399	0.004	CcSEcCtD
Chlorzoxazone—Somnolence—Epirubicin—urinary bladder cancer	0.000384	0.00385	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000381	0.00382	CcSEcCtD
Chlorzoxazone—Dyspepsia—Epirubicin—urinary bladder cancer	0.00038	0.00381	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000373	0.00374	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000356	0.00357	CcSEcCtD
Chlorzoxazone—Somnolence—Doxorubicin—urinary bladder cancer	0.000356	0.00356	CcSEcCtD
Chlorzoxazone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000352	0.00353	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000345	0.00346	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00033	0.0033	CcSEcCtD
Chlorzoxazone—Dizziness—Methotrexate—urinary bladder cancer	0.000305	0.00306	CcSEcCtD
Chlorzoxazone—Rash—Methotrexate—urinary bladder cancer	0.000291	0.00292	CcSEcCtD
Chlorzoxazone—Dermatitis—Methotrexate—urinary bladder cancer	0.000291	0.00292	CcSEcCtD
Chlorzoxazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000287	0.00128	CbGpPWpGaD
Chlorzoxazone—Dizziness—Epirubicin—urinary bladder cancer	0.000286	0.00287	CcSEcCtD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000283	0.00127	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.00028	0.00125	CbGpPWpGaD
Chlorzoxazone—Rash—Epirubicin—urinary bladder cancer	0.000273	0.00273	CcSEcCtD
Chlorzoxazone—Dermatitis—Epirubicin—urinary bladder cancer	0.000272	0.00273	CcSEcCtD
Chlorzoxazone—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000271	0.00121	CbGpPWpGaD
Chlorzoxazone—Dizziness—Doxorubicin—urinary bladder cancer	0.000264	0.00265	CcSEcCtD
Chlorzoxazone—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000264	0.00118	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000263	0.00118	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—TP53—urinary bladder cancer	0.000262	0.00117	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000261	0.00117	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00026	0.00116	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—CREBBP—urinary bladder cancer	0.000257	0.00115	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	0.000257	0.00115	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000255	0.00114	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000255	0.00114	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—IGF1—urinary bladder cancer	0.000254	0.00113	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000253	0.00113	CbGpPWpGaD
Chlorzoxazone—Rash—Doxorubicin—urinary bladder cancer	0.000252	0.00253	CcSEcCtD
Chlorzoxazone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000252	0.00253	CcSEcCtD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000243	0.00109	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000243	0.00109	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000243	0.00108	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000242	0.00108	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000241	0.00108	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000239	0.00107	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	0.000236	0.00106	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000233	0.00104	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—RHOA—urinary bladder cancer	0.000232	0.00104	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.00023	0.00103	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.00023	0.00103	CbGpPWpGaD
Chlorzoxazone—CYP1A1—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000228	0.00102	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000223	0.000998	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000223	0.000996	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000223	0.000995	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000222	0.000991	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000219	0.000981	CbGpPWpGaD
Chlorzoxazone—CYP1A1—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000219	0.000979	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000219	0.000977	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000215	0.000961	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000215	0.000959	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.000214	0.000958	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000213	0.000952	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000205	0.000917	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000201	0.000898	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	0.000199	0.00089	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—IL2—urinary bladder cancer	0.000195	0.000871	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Neuronal System—HRAS—urinary bladder cancer	0.000193	0.000862	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000191	0.000854	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000191	0.000854	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	0.000189	0.000844	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NAT1—urinary bladder cancer	0.000189	0.000844	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000186	0.000831	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000186	0.000831	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000182	0.000815	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.00018	0.000804	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000177	0.000792	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—EP300—urinary bladder cancer	0.000175	0.000782	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	0.000173	0.000772	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000172	0.000768	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—SRC—urinary bladder cancer	0.00017	0.00076	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000168	0.000749	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000167	0.000744	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000166	0.000741	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000165	0.000738	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000163	0.000728	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000163	0.000728	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000157	0.000703	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	0.000155	0.000695	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000155	0.000693	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000155	0.000693	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000154	0.00069	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000154	0.000688	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.000154	0.000687	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000152	0.000681	CbGpPWpGaD
Chlorzoxazone—CYP1A1—PPARA activates gene expression—EP300—urinary bladder cancer	0.000149	0.000667	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000149	0.000667	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000149	0.000667	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	0.000148	0.000663	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000148	0.00066	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	0.000147	0.000656	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000146	0.000653	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	0.000143	0.000639	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000142	0.000634	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—KRAS—urinary bladder cancer	0.000141	0.00063	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NAT1—urinary bladder cancer	0.000141	0.000629	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	0.000141	0.000629	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00014	0.000626	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000138	0.000618	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	0.000136	0.00061	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000131	0.000585	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	0.000129	0.000575	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—TP53—urinary bladder cancer	0.000125	0.00056	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	0.000123	0.000549	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—HRAS—urinary bladder cancer	0.00012	0.000535	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000119	0.000533	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000118	0.000525	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	0.000116	0.000519	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	0.000116	0.000518	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—TYMP—urinary bladder cancer	0.000114	0.000511	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	0.000113	0.000505	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000112	0.000499	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.00011	0.000489	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	0.000109	0.000489	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000108	0.000483	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	0.000107	0.000476	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000106	0.000473	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000106	0.000473	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NAT2—urinary bladder cancer	0.000103	0.000462	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000101	0.00045	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	9.68e-05	0.000433	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	9.46e-05	0.000423	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—TYMP—urinary bladder cancer	9.04e-05	0.000404	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	8.97e-05	0.000401	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NAT1—urinary bladder cancer	8.97e-05	0.000401	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—RRM2—urinary bladder cancer	8.93e-05	0.000399	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.82e-05	0.000394	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	8.72e-05	0.00039	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.55e-05	0.000382	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—TYMP—urinary bladder cancer	8.52e-05	0.000381	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ENO2—urinary bladder cancer	8.27e-05	0.00037	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	8.27e-05	0.00037	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	8.23e-05	0.000368	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	8.2e-05	0.000367	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.18e-05	0.000366	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NAT2—urinary bladder cancer	8.17e-05	0.000365	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	8.02e-05	0.000359	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	8.02e-05	0.000358	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NAT2—urinary bladder cancer	7.71e-05	0.000344	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	7.38e-05	0.00033	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.3e-05	0.000326	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—RRM2—urinary bladder cancer	7.06e-05	0.000315	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	6.97e-05	0.000312	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.92e-05	0.000309	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.92e-05	0.000309	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	6.8e-05	0.000304	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NQO1—urinary bladder cancer	6.66e-05	0.000298	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—RRM2—urinary bladder cancer	6.65e-05	0.000297	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	6.53e-05	0.000292	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ENO2—urinary bladder cancer	6.53e-05	0.000292	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—TYMP—urinary bladder cancer	6.41e-05	0.000287	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	6.34e-05	0.000283	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.33e-05	0.000283	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	6.16e-05	0.000275	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ENO2—urinary bladder cancer	6.16e-05	0.000275	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.12e-05	0.000274	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	5.97e-05	0.000267	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.88e-05	0.000263	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.8e-05	0.000259	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.7e-05	0.000255	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	5.56e-05	0.000248	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.45e-05	0.000244	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—TYMP—urinary bladder cancer	5.43e-05	0.000243	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.38e-05	0.000241	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NQO1—urinary bladder cancer	5.27e-05	0.000235	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.24e-05	0.000234	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.22e-05	0.000233	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—TYMS—urinary bladder cancer	5.17e-05	0.000231	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	5.11e-05	0.000228	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	5.11e-05	0.000228	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—RRM2—urinary bladder cancer	5.01e-05	0.000224	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NQO1—urinary bladder cancer	4.97e-05	0.000222	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NAT2—urinary bladder cancer	4.91e-05	0.00022	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GPX1—urinary bladder cancer	4.89e-05	0.000219	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.82e-05	0.000215	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	4.8e-05	0.000215	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.64e-05	0.000207	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.64e-05	0.000207	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	4.51e-05	0.000202	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.5e-05	0.000201	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	4.39e-05	0.000196	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—RRM2—urinary bladder cancer	4.24e-05	0.00019	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.2e-05	0.000188	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.19e-05	0.000187	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	4.14e-05	0.000185	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—TYMS—urinary bladder cancer	4.08e-05	0.000183	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	4.04e-05	0.00018	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	4.04e-05	0.00018	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.01e-05	0.000179	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.93e-05	0.000176	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.93e-05	0.000176	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.9e-05	0.000175	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.87e-05	0.000173	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—TYMS—urinary bladder cancer	3.85e-05	0.000172	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.81e-05	0.00017	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	3.81e-05	0.00017	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	3.81e-05	0.00017	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	3.8e-05	0.00017	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.79e-05	0.000169	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.75e-05	0.000168	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.74e-05	0.000167	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPARG—urinary bladder cancer	3.66e-05	0.000164	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GPX1—urinary bladder cancer	3.64e-05	0.000163	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	3.58e-05	0.00016	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	3.57e-05	0.000159	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	3.52e-05	0.000157	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	3.36e-05	0.00015	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.27e-05	0.000146	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NQO1—urinary bladder cancer	3.17e-05	0.000142	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.12e-05	0.000139	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.07e-05	0.000137	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.03e-05	0.000135	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.03e-05	0.000135	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.94e-05	0.000131	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.9e-05	0.00013	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.89e-05	0.000129	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	2.88e-05	0.000129	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.86e-05	0.000128	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.86e-05	0.000128	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.78e-05	0.000124	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.74e-05	0.000123	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPARG—urinary bladder cancer	2.73e-05	0.000122	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.69e-05	0.00012	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.68e-05	0.00012	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.64e-05	0.000118	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	2.62e-05	0.000117	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.55e-05	0.000114	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.53e-05	0.000113	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PTEN—urinary bladder cancer	2.51e-05	0.000112	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.45e-05	0.00011	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.44e-05	0.000109	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.43e-05	0.000108	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.43e-05	0.000108	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—EP300—urinary bladder cancer	2.4e-05	0.000107	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.32e-05	0.000104	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.28e-05	0.000102	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	2.28e-05	0.000102	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	2.15e-05	9.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.14e-05	9.59e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.05e-05	9.18e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.04e-05	9.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.98e-05	8.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.97e-05	8.81e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.89e-05	8.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.89e-05	8.46e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.87e-05	8.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.87e-05	8.37e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PTEN—urinary bladder cancer	1.87e-05	8.36e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.79e-05	8.02e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—EP300—urinary bladder cancer	1.78e-05	7.98e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.76e-05	7.87e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.74e-05	7.77e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.67e-05	7.47e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.66e-05	7.4e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.61e-05	7.22e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.41e-05	6.29e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.37e-05	6.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.34e-05	6e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.34e-05	6e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.29e-05	5.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.19e-05	5.33e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.14e-05	5.09e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.06e-05	4.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.21e-06	4.12e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.78e-06	3.92e-05	CbGpPWpGaD
